Table 1 Distributions of cases (lithium responders) and controls (non-responders) across sites.
Institution | Responders | Non-responders |
|---|---|---|
University of Cagliari, Italy | 55 (28%) | 141 (72%) |
Dalhousie University, Canada | 159 (45%) | 194 (55%) |
University of NSW, Australia | 13 (20%) | 50 (80%) |
Poznan University of Medical Sciences, Poland | 47 (48%) | 50 (52%) |
UC San Diego, USA | 23 (11%) | 192 (89%) |
RIKEN Brain Institute, Japan | 31 (24%) | 97 (76%) |
Mayo Clinic, USA | 22 (23%) | 72 (77%) |
University of Würzburg, Germany | 30 (17%) | 145 (83%) |
Karolinska Institutet, Sweden | 138 (45%) | 166 (55%) |
National Taiwan University, Taiwan | 13 (14%) | 79 (86%) |
Obregia Hospital, Romania | 32 (21%) | 120 (79%) |
University of Geneva, Switzerland | 13 (23%) | 44 (77%) |
University of Barcelona, Spain | 20 (27%) | 54 (73%) |
INSERM, France | 38 (18%) | 172 (82%) |
ALL | 634 (29%) | 1576 (71%) |
